Nils-Henning Neß

Differentiating societal costs of disability worsening in multiple sclerosis

Nils-Henning Neß, Dirk Schriefer, Rocco Haase et al. · Journal of Neurology · 2019 · 43 citations · Full text

Pharmacy, Neurology, Pharmacoeconomics +9

The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study

Nils-Henning Neß, Rocco Haase, Raimar Kern et al. · Journal of Medical Internet Research · 2020 · 25 citations · Full text

Pharmacy, Neurology, Pharmacoeconomics +17

Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients

Dirk Schriefer, Nils-Henning Neß, Rocco Haase et al. · Therapeutic Advances in Neurological Disorders · 2020 · 22 citations · Full text

Pharmacy, Pharmacoeconomics, Health Economics +16

Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis

Nils-Henning Neß, Dirk Schriefer, Rocco Haase et al. · PharmacoEconomics · 2020 · 13 citations · Full text

Pharmacy, Pharmacoeconomics, Resource Economics +17

Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis – real-world evidence from Germany

Steffeni Papukchieva, Ann-Sophie Stratil, Maria Kahn et al. · Therapeutic Advances in Neurological Disorders · 2024 · 13 citations · Full text

Pharmacy, Pharmacotherapy, Pharmacy Practice +17